NCT01446419已完成不适用
A Prospective Randomized, Double-blind, Controlled Investigation Evaluating the Intracept Intraosseous Nerve Ablation System for the Reduction of Pain in Patients With Chronic Axial Low Back Pain
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 225
- 试验地点
- 26
- 主要终点
- Change in ODI From Baseline to 3 Months Post-treatment
研究概览
简要总结
To evaluate the safety and efficacy of RF ablation using the Intracept Intraosseous Nerve Ablation System to ablate intraosseous nerves for the relief of chronic axial low back pain. This is a prospective, double-blind, randomized, sham-controlled clinical trial with an optional crossover component.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Crossover
- 主要目的
- Treatment
- 盲法
- Double (Participant, Outcomes Assessor)
入排标准
- 年龄范围
- 25 Years 至 70 Years（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Skeletally mature patients age 25 - 70 years, inclusive
- •Chronic lower back pain for at least six (6) months
- •Failure to respond to at least six (6) months of non-operative conservative management. The minimum requirement is as follows:
- •Analgesic therapy (minimum of 2 weeks) and a minimum of 4 weeks of NSAID therapy
- •Supervised exercise program(minimum of 12 sessions)
- •Oswestry Disability Index (ODI) at time of evaluation of at least 30 points
- •Baseline Visual Analog Scale (VAS) of at least 4cm on a 10cm scale
- •The following test indicating that the vertebral body is the source of pain:
- •1.MRI showing Type 1 or Type II Modic changes at least one vertebral endplate, at one or more levels from L3 to S1
- •Understands the local language and is willing and able to follow the requirements of the protocol
- •Understands the informed consent and signs the institutional review board/ independent ethics committee (IRB/IEC) approved informed consent form
排除标准
- •Radicular pain by history or evidence of pain or neurological deficit in a dermatomal zone at or below the medial thigh.
- •Previous surgery performed on the lumbar spine
- •History of symptomatic spinal stenosis
- •History of osteoporotic or tumor-related vertebral body compression fracture
- •History of vertebral cancer or spinal metastasis
- •History of spinal infection
- •Metabolic bone disease (e.g. osteogenesis imperfecta)
- •Osteoporosis, defined as T score <-2.5
- •Any radiographic evidence of other important back pathology, such as:
- •Nerve root compression or severe effacement of the thecal sac that correlates with radicular pain or muscle weakness
- •Disc extrusion or disc protrusion >5mm
- •Facet arthrosis or facet effusion at any lumbar level that correlates with clinical evidence of facet mediated low back pain
- •Spondylolisthesis 2mm or greater at any level
- •Spondylolysis at any level
- •MRI evidence of Modic changes, Type I or Type II at greater than 3 vertebral bodies.
- •Any back pathology related to trauma, evidence of vertebral compression fracture or other spinal pathology that could affect assessment of response to back pain
- •Demonstrates 3 or more Waddell's signs of Inorganic Behavior
- •Any evidence of current systemic infection
- •Uncorrected bleeding diathesis
- •Any neurologic problem that prevents early mobilization after surgery or interferes with assessment of ODI
- •Contraindication to MRI or patients who have allergies to the components of the Intracept device
- •Pregnant, lactating or plan to become pregnant in next year
- •Diabetes requiring daily insulin
- •Current use of steroid therapy, with the exception of inhalation steroids for asthma
- •Evidence of mental instability or uncontrolled depression; patients requiring anti-depressants or anti-psychotics within 3 months of enrollment are not eligible; patients with a Beck Depression Score of greater than 24 are not eligible
- •Receiving Workmen's Compensation
- •Currently involved in litigation regarding back pain/injury or financial incentive to remain impaired
- •Any medical condition that impairs follow-up
- •Contraindications to the proposed anesthetic protocol.
- •Evidence of substance abuse; patients using prescribed extended release narcotics are not eligible (e.g. fentanyl patch,MS contin, oxycontin)
- •Known to require at the time of screening and/or randomization, additional surgery to the lumbar spinal region within six months
- •Being treated with radiation, chemotherapy, immunosuppression, or chronic steroid therapy (prednisone use up to 5 mg/qd or its equivalent is allowed)
- •Has a life expectancy of less than 1 year
- •Has active implantable devices, such as cardiac pacemakers, spinal cord stimulators, etc.
- •Is a prisoner
结局指标
主要结局
Change in ODI From Baseline to 3 Months Post-treatment
时间窗: 3 months
The primary variable is the Oswestry Disability Index (ODI) and the primary efficacy endpoint is the mean improvement from baseline to 3 months in the ODI. The primary endpoint will be evaluated in both the treatment and sham groups with between-group comparisons used to assess the success of the Intracept System in reducing chronic axial low back pain. ODI is a patient questionnaire that assesses back dysfunction due to back pain. There are 10 questions that are scored from 0-5. The obtained score is multiplied by 2 to produce a percentage score that is reported on a scale of 0-100. Scores are interpreted as follows: 0-20% minimum disability; 21-40% moderate disability; 41-60% severe disability; 61-80% crippled; 81-100% bed bound or exaggerating their symptoms.
次要结局
- Patient Success at 3 Months(3 months)
- Change in ODI From Baseline to 6 Months Post-treatment(6 months)
研究者
研究点 (26)
Loading locations...
相似试验
尚未招募
不适用
A Prospective Clinical Study on the Safety and Efficacy of Radiofrequency Ablation for the Treatment of Patients With Desmoid TumorsDesmoid TumorDesmoid FibromatosisDesmoidNCT06355921Blokhin's Russian Cancer Research Center27
已完成
不适用
Intramural Needle Ablation for the Treatment of Refractory Ventricular ArrhythmiasVentricular ArrythmiaNCT03204981Vivek Reddy52
已完成
不适用
Evaluation of Conventional Ablation With or Without Focal Impulse and Rotor Modulation to Eliminate Human AFAtrial FibrillationNCT02456233Stanford University84
Unknown
不适用
Radiofrequency Ablation of Malignant Pulmonary NodulesNeoplasmsCarcinomaNCT02629978Chinese PLA General Hospital500
已完成
不适用
Genicular Nerve Radiofrequency Ablation for Chronic Knee Pain After Total Knee ArthroplastyTotal Knee ArthroplastyNCT05130216University of Utah5